ArticleOncoimmunology2026

Circadian timing of first-line chemoimmunotherapy is associated with survival in extensive-stage small cell lung cancer.

Mehmet Haluk Yucel et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.